Current status, goals, and research agenda for outcome measures development in Behçet syndrome: Report from OMERACT 2014

Journal of Rheumatology

Volumn 42, Issue 12, 2015, Pages 2436-2441

  Hatemi, Gulen ^a   Ozguler, Yesim ^a   Direskeneli, Haner ^b   Mahr, Alfred ^c   Gul, Ahmet ^a   Levi, Virna ^d   Aydin, Sibel Z ^e   Mumcu, Gonca ^b   Sertel Berk, Ozlem ^f   Stevens, Randall M ^g   Yazici, Hasan ^d   Merkel, Peter A ^h  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Patient Research Partner   (Turkey)

^e KOÇ UNIVERSITY   (Turkey)

^f ISTANBUL UNIVERSITY   (Turkey)

^g CELGENE CORPORATION   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Beh et syndrome; Outcome measures; Outcomes

Indexed keywords

ANALYTICAL PARAMETERS; ARTICLE; BEHCET DISEASE; CLINICAL RESEARCH; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE-SPECIFIC MEASURE; GENERIC MEASURE; HUMAN; LONGITUDINAL STUDY; MEDICAL RESEARCH; ORGAN-SPECIFIC MEASURE; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; RELIABILITY; VALIDATION STUDY; ADULT; AGED; BEHCET SYNDROME; CONSENSUS DEVELOPMENT; FEMALE; MALE; MIDDLE AGED; PRACTICE GUIDELINE; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOLOGY; STANDARDS; UNITED STATES;

ADULT; AGED; BEHCET SYNDROME; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHEUMATOLOGY; UNITED STATES;

EID: 84948807754     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.141147     Document Type: Article

References (12)

1. Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 2003;82:60-76.
2. Yazici H, Tüzün Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdogan H, et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984;43:783-9.
3. Hamuryudan V, Hatemi G, Tascilar K, Sut N, Ozyazgan Y, Seyahi E, et al. Prognosis of Behçet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial. Rheumatology 2010; 49:173-7.
4. Hatemi G, Merkel PA, Hamuryudan V, Boers M, Direskeneli H, Aydin SZ, et al. Outcome measures used in clinical trials for Behçet syndrome: a systematic review. J Rheumatol 2014;41:599-612.
5. Yazici H, Ugurlu S, Seyahi E. Behçet syndrome: is it one condition? Clin Rev Allergy Immunol 2012;43:275-80.
6. Gilworth G, Chamberlain MA, Bhakta B, Haskard D, Silman A, Tennant A. Development of the BD-QoL: a quality of life measure specific to Behçet's disease. J Rheumatol 2004;31:931-7.
7. Forbess C, Swearingen C, Yazici Y. Behçet's Syndrome Activity Score (BSAS): a new disease activity assessment tool, composed of patient-derived measures only, is strongly correlated with the Behçet's Disease Current Activity Form (BDCAF) [abstract]. Arthritis Rheum 2008;58 Suppl 9:S854.
8. Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol 2014;67:745-53.
9. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
10. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122 Pt 5:871-82.
11. Gilworth G, Chamberlain MA, Bhakta B, Haskard D, Silman A, Tennant A. Development of the BD-QoL: a quality of life measure specific to Behçet's disease. J Rheumatol 2004;31:931-7.
12. Locker D, Slade G. Oral health and the quality of life among older adults: the oral health impact profile. J Can Dent Assoc 1993;59:830-3;837-8;844.